The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 22, 2024 | Brightstar Associates LLC | 10% Owner | Option exercise(X) | 48K | $0.01 | $481 |
| Apr 22, 2024 | Brightstar Associates LLC | 10% Owner | Option exercise(X) | 48K | — | $0 |
| Feb 16, 2024 | Pitman Jama | SVP, Chief Development Officer | Sell(S) | 2K | $15.62 | $35K |
| Feb 16, 2024 | Sherman Matthew L | EVP & Chief Medical Officer | Sell(S) | 3K | $15.62 | $41K |
| Feb 16, 2024 | Martin Daniel C. | Chief Commercial Officer | Sell(S) | 2K | $15.62 | $35K |
| Feb 16, 2024 | Kelly Thomas Patrick | Chief Financial Officer | Sell(S) | 3K | $15.62 | $47K |
| Feb 15, 2024 | Pitman Jama | SVP, Chief Development Officer | Grant(A) | 10K | — | $0 |
| Feb 15, 2024 | Pitman Jama | SVP, Chief Development Officer | Grant(A) | 10K | — | $0 |
| Feb 15, 2024 | Pitman Jama | SVP, Chief Development Officer | Grant(A) | 39K | — | $0 |
| Feb 15, 2024 | Sherman Matthew L | EVP & Chief Medical Officer | Grant(A) | 17K | — | $0 |
| Feb 15, 2024 | Sherman Matthew L | EVP & Chief Medical Officer | Grant(A) | 69K | — | $0 |
| Feb 15, 2024 | Martin Daniel C. | Chief Commercial Officer | Grant(A) | 10K | — | $0 |
| Feb 15, 2024 | Martin Daniel C. | Chief Commercial Officer | Grant(A) | 39K | — | $0 |
| Feb 15, 2024 | Dhanak Dashyant | EVP & Chief Scientific Officer | Grant(A) | 17K | — | $0 |
| Feb 15, 2024 | Dhanak Dashyant | EVP & Chief Scientific Officer | Grant(A) | 69K | — | $0 |
| Feb 15, 2024 | Hoerter Steven L. | President and CEO, Director | Grant(A) | 298K | — | $0 |
| Feb 15, 2024 | Kelly Thomas Patrick | Chief Financial Officer | Grant(A) | 17K | — | $0 |
| Feb 15, 2024 | Kelly Thomas Patrick | Chief Financial Officer | Grant(A) | 69K | — | $0 |
| Feb 7, 2024 | Brightstar Associates LLC | 10% Owner | Option exercise(X) | 914K | $0.01 | $9K |
| Feb 7, 2024 | Brightstar Associates LLC | 10% Owner | Option exercise(X) | 914K | — | $0 |
| Jan 16, 2024 | Allen Patricia L | Director | Grant(A) | 5K | $10.58 | $50K |
| Jan 16, 2024 | Squarer Ron | Director | Grant(A) | 5K | $10.58 | $50K |
| Jan 16, 2024 | Martin Daniel C. | Chief Commercial Officer | Sell(S) | 2K | $14.47 | $23K |
| Jan 16, 2024 | Kelly Thomas Patrick | Chief Financial Officer | Sell(S) | 2K | $14.47 | $35K |
| Jan 16, 2024 | Friedman Franklin Stuart | Director | Grant(A) | 5K | $10.58 | $50K |
| Jan 16, 2024 | Pitman Jama | SVP, Chief Development Officer | Sell(S) | 2K | $14.47 | $23K |
| Jan 16, 2024 | Walsh Dennis Leo | Director | Grant(A) | 5K | $10.58 | $50K |
| Jan 16, 2024 | Sherman Matthew L | EVP & Chief Medical Officer | Sell(S) | 2K | $14.47 | $35K |
| Dec 13, 2023 | Sherman Matthew L | EVP & Chief Medical Officer | Sell(S) | 3K | $15.37 | $43K |
| Dec 13, 2023 | Martin Daniel C. | Chief Commercial Officer | Sell(S) | 2K | $15.37 | $27K |
| Dec 13, 2023 | Kelly Thomas Patrick | Chief Financial Officer | Sell(S) | 3K | $15.37 | $43K |
| Dec 13, 2023 | Pitman Jama | See Remarks | Sell(S) | 2K | $15.37 | $26K |
| Dec 13, 2023 | Hoerter Steven L. | President and CEO, Director | Sell(S) | 31K | $15.37 | $471K |
| Dec 12, 2023 | Sherman Matthew L | EVP & Chief Medical Officer | Grant(A) | 8K | — | — |
| Dec 12, 2023 | Martin Daniel C. | Chief Commercial Officer | Grant(A) | 6K | — | — |
| Dec 12, 2023 | Kelly Thomas Patrick | Chief Financial Officer | Grant(A) | 8K | — | — |
| Dec 12, 2023 | Pitman Jama | See Remarks | Grant(A) | 6K | — | — |
| Dec 12, 2023 | Hoerter Steven L. | President and CEO, Director | Grant(A) | 63K | — | — |
| Nov 30, 2023 | Martin Daniel C. | Chief Commercial Officer | Sell(S) | 18K | $12.57 | $224K |
| Oct 30, 2023 | Hoerter Steven L. | President and CEO, Director | Sell(S) | 22K | $12.02 | $259K |
| Oct 30, 2023 | Kelly Thomas Patrick | Chief Financial Officer | Sell(S) | 2K | $12.02 | $28K |
| Oct 30, 2023 | Martin Daniel C. | Chief Commercial Officer | Sell(S) | 1K | $12.02 | $17K |
| Oct 30, 2023 | Pitman Jama | See Remarks | Sell(S) | 1K | $12.02 | $17K |
| Oct 30, 2023 | Sherman Matthew L | EVP & Chief Medical Officer | Sell(S) | 2K | $12.02 | $28K |
| Oct 28, 2023 | Hoerter Steven L. | President and CEO, Director | Grant(A) | 63K | — | — |
| Oct 28, 2023 | Kelly Thomas Patrick | Chief Financial Officer | Grant(A) | 8K | — | — |
| Oct 28, 2023 | Martin Daniel C. | Chief Commercial Officer | Grant(A) | 6K | — | — |
| Oct 28, 2023 | Pitman Jama | See Remarks | Grant(A) | 6K | — | — |
| Oct 28, 2023 | Sherman Matthew L | EVP & Chief Medical Officer | Grant(A) | 8K | — | — |
| Oct 2, 2023 | Sherman Matthew L | EVP & Chief Medical Officer | Sell(S) | 3K | $12.68 | $37K |
| Sep 15, 2023 | Dhanak Dashyant | EVP & Chief Scientific Officer | Grant(A) | 75K | — | $0 |
| Sep 15, 2023 | Dhanak Dashyant | EVP & Chief Scientific Officer | Grant(A) | 66K | — | $0 |
| Sep 15, 2023 | Dhanak Dashyant | EVP & Chief Scientific Officer | Grant(A) | 66K | — | $0 |
| Jun 21, 2023 | Allen Patricia L | Director | Grant(A) | 30K | — | $0 |
| Jun 21, 2023 | Friedman Franklin Stuart | Director | Grant(A) | 30K | — | $0 |
| Jun 21, 2023 | Kelley Susan L. | Director | Grant(A) | 30K | — | $0 |
| Jun 21, 2023 | Benz Edward J. JR | Director | Grant(A) | 30K | — | $0 |
| Jun 21, 2023 | Martin John Richard | Director | Grant(A) | 30K | — | $0 |
| Jun 21, 2023 | Squarer Ron | Director | Grant(A) | 30K | — | $0 |
| Jun 21, 2023 | Walsh Dennis Leo | Director | Grant(A) | 30K | — | $0 |
| Jun 21, 2023 | Bristol James Arthur | Director | Grant(A) | 30K | — | $0 |
| Jun 16, 2023 | Flynn Daniel Lee | Chief Scientific Officer | Sell(S) | 2K | $14.40 | $24K |
| Jun 16, 2023 | Martin Daniel C. | Chief Commercial Officer | Sell(S) | 1K | $14.40 | $18K |
| Jun 16, 2023 | Kelly Thomas Patrick | Chief Financial Officer | Sell(S) | 2K | $14.40 | $24K |
| Jun 16, 2023 | Sherman Matthew L | EVP & Chief Medical Officer | Sell(S) | 2K | $14.40 | $24K |
| Jun 16, 2023 | Pitman Jama | See Remarks | Sell(S) | 1K | $14.40 | $18K |
| Jun 8, 2023 | Friedman Franklin Stuart | Director | Buy(P) | 10K | $13.88 | $139K |
| May 10, 2023 | Walsh Dennis Leo | Director | Buy(P) | 11K | $13.86 | $152K |
| Mar 21, 2023 | Hoerter Steven L. | President and CEO, Director | Sell(S) | 8K | $15.57 | $117K |
| Feb 28, 2023 | Brightstar Associates LLC | 10% Owner | Option exercise(X) | 2.4M | $0.01 | $24K |
| Feb 28, 2023 | Brightstar Associates LLC | 10% Owner | Option exercise(X) | 2.4M | — | $0 |
| Feb 16, 2023 | Flynn Daniel Lee | Chief Scientific Officer | Sell(S) | 1K | $15.10 | $21K |
| Feb 16, 2023 | Sherman Matthew L | EVP & Chief Medical Officer | Sell(S) | 971 | $15.10 | $15K |
| Feb 16, 2023 | Kelly Thomas Patrick | Chief Financial Officer | Sell(S) | 1K | $15.10 | $21K |
| Feb 16, 2023 | Martin Daniel C. | Chief Commercial Officer | Sell(S) | 1K | $15.10 | $18K |
| Feb 16, 2023 | Pitman Jama | See Remarks | Sell(S) | 1K | $15.10 | $18K |
| Feb 15, 2023 | Hoerter Steven L. | President and CEO, Director | Grant(A) | 250K | — | $0 |
| Feb 15, 2023 | Flynn Daniel Lee | Chief Scientific Officer | Grant(A) | 16K | — | $0 |
| Feb 15, 2023 | Flynn Daniel Lee | Chief Scientific Officer | Grant(A) | 66K | — | $0 |
| Feb 15, 2023 | Sherman Matthew L | EVP & Chief Medical Officer | Grant(A) | 16K | — | $0 |
| Feb 15, 2023 | Sherman Matthew L | EVP & Chief Medical Officer | Grant(A) | 66K | — | $0 |
| Feb 15, 2023 | Kelly Thomas Patrick | Chief Financial Officer | Grant(A) | 16K | — | $0 |
| Feb 15, 2023 | Kelly Thomas Patrick | Chief Financial Officer | Grant(A) | 66K | — | $0 |
| Feb 15, 2023 | Martin Daniel C. | Chief Commercial Officer | Grant(A) | 11K | — | $0 |
| Feb 15, 2023 | Martin Daniel C. | Chief Commercial Officer | Grant(A) | 45K | — | $0 |
| Feb 15, 2023 | Pitman Jama | See Remarks | Grant(A) | 11K | — | $0 |
| Feb 15, 2023 | Pitman Jama | See Remarks | Grant(A) | 45K | — | $0 |
| Feb 14, 2023 | Hoerter Steven L. | President and CEO, Director | Sell(S) | 30K | $16.00 | $481K |
| Jan 24, 2023 | Brightstar Associates LLC | 10% Owner | Buy(P) | 1.7M | $18.00 | $30.0M |
| Jan 17, 2023 | Kelley Susan L. | Director | Grant(A) | 3K | $15.30 | $50K |
| Jan 17, 2023 | Squarer Ron | Director | Grant(A) | 3K | $15.30 | $50K |
| Jan 17, 2023 | Kelly Thomas Patrick | Chief Financial Officer | Sell(S) | 2K | $21.24 | $51K |
| Jan 17, 2023 | Walsh Dennis Leo | Director | Grant(A) | 3K | $15.30 | $50K |
| Jan 17, 2023 | Martin Daniel C. | Chief Commercial Officer | Sell(S) | 2K | $21.24 | $34K |
| Jan 17, 2023 | Allen Patricia L | Director | Grant(A) | 3K | $15.30 | $50K |
| Jan 17, 2023 | Sherman Matthew L | EVP & Chief Medical Officer | Sell(S) | 2K | $21.24 | $51K |
| Jan 17, 2023 | Pitman Jama | See Remarks | Sell(S) | 2K | $21.24 | $34K |
| Jan 17, 2023 | Flynn Daniel Lee | Chief Scientific Officer | Sell(S) | 2K | $21.24 | $51K |
| Jan 17, 2023 | Friedman Franklin Stuart | Director | Grant(A) | 3K | $15.30 | $50K |
| Oct 3, 2022 | Sherman Matthew L | EVP & Chief Medical Officer | Sell(S) | 3K | $18.73 | $48K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).